Mel Gibson’s claims about controversial unproven cancer drug on Joe Rogan spark huge rise in prescriptions

✕ Sensationalism: The headline uses 'huge rise' and attributes a causal-like effect to Mel Gibson's claims, which may overstate the study's findings that only show correlation, not causation. This could mislead readers about the strength of evidence.

"Mel Gibson’s claims about controversial unproven cancer drug on Joe Rogan spark huge rise in prescriptions"

✕ Editorializing: The lead introduces a catchy phrase 'celebrity science' which frames the topic in a dismissive and editorialized tone, potentially undermining neutral presentation.

"You’ve heard of pseudoscience — but what about celebrity science?"

✓ Balanced Reporting: The article uses neutral, factual language when presenting scientific findings and avoids emotional appeals when discussing patient risks.

"To date, no human clinical trials have shown that ivermectin and fenbendazole are safe or effective for treating cancer."

✓ Balanced Reporting: It avoids inflammatory language when discussing misinformation, instead focusing on expert caution and evidence gaps.

"Using unproven treatments can carry real risks, especially if it delays care that is known to work"

✕ Loaded Language: The use of 'bombshell claim' introduces a mildly sensational tone that slightly undermines objectivity.

"a bombshell claim from Mel Gibson on influencer Joe Rogan’s popular podcast"

✓ Proper Attribution: Quotes multiple independent experts including researchers from UCLA and University of Utah, with clear attribution and institutional affiliations.

"Dr. Skyler B. Johnson of the University of Utah Huntsman Cancer Institute"

✓ Proper Attribution: Includes direct quotes from study authors with their full titles and affiliations, enhancing credibility.

"Dr. John N. Mafi, senior author of the UCLA-led study"

✓ Balanced Reporting: Presents expert consensus on lack of evidence without giving undue weight to fringe views, maintaining scientific balance.

"Experts caution there is little clinical evidence to support the drugs for this use."

✓ Comprehensive Sourcing: The article acknowledges the lack of human clinical trials and explains that lab results require toxic doses, providing crucial context about the implausibility of the treatment.

"To date, no human clinical trials have shown that ivermectin and fenbendazole are safe or effective for treating cancer."

✓ Comprehensive Sourcing: It notes that the study does not prove causation between the podcast and prescription increases, which is essential context often omitted in similar reporting.

"The researchers stressed that the study does not prove the podcast directly caused the spike in prescriptions."

✓ Comprehensive Sourcing: The article includes information about ongoing preclinical research by the National Cancer Institute, adding balance about future possibilities without overstating current evidence.

"And while the National Cancer Institute announced earlier this year that it is studying ivermectin’s possible anti-cancer properties, the research remains in the preclinical stage — meaning any findings are still far from being ready for actual patients."